Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycerol + fructose is a combination pharmaceutical formulation used primarily for the treatment of elevated intracranial pressure and cerebral edema. The combination leverages the osmotic properties of both components to promote dehydration of brain tissue, thereby reducing intracranial pressure. Glycerol acts as an osmotic agent that draws water out from tissues into the bloodstream, while fructose serves as a carbohydrate source that can be metabolized via glycolysis and the tricarboxylic acid cycle. This combination is often administered intravenously in clinical settings for conditions such as cerebral hemorrhage with brain edema or other causes of increased intracranial pressure[1][2][3][7]. Clinical studies have shown significant improvement in neurological symptoms associated with high intracranial pressure following administration[1]. The formulation may also include sodium chloride to maintain electrolyte balance[1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycerol + fructose.